Xtant Medical Holdings Stock Today
| XTNT Stock | USD 0.40 0.01 2.44% |
Performance0 of 100
| Odds Of DistressOver 61
|
Xtant Medical is selling for under 0.4 as of the 28th of November 2024; that is 2.44 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.4. Xtant Medical has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Xtant Medical Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of October 2015 | Category Healthcare | Classification Health Care |
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. The company has 139.01 M outstanding shares of which 197.47 K shares are at this time shorted by private and institutional investors with about 6.92 trading days to cover. More on Xtant Medical Holdings
Moving against Xtant Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Xtant Stock Highlights
| CEO President | Sean Browne | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Drugs (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsXtant Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Xtant Medical's financial leverage. It provides some insight into what part of Xtant Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xtant Medical Holdings (XTNT) is traded on NYSE MKT Exchange in USA. It is located in 664 Cruiser Lane, Belgrade, MT, United States, 59714 and employs 207 people. Xtant Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.6 M. Xtant Medical Holdings conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 139.01 M outstanding shares of which 197.47 K shares are at this time shorted by private and institutional investors with about 6.92 trading days to cover.
Xtant Medical Holdings currently holds about 16.5 M in cash with (9.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check Xtant Medical Probability Of Bankruptcy
Ownership AllocationXtant Medical Holdings retains a total of 139.01 Million outstanding shares. Over half of Xtant Medical's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Xtant Ownership Details
Xtant Medical Historical Income Statement
Xtant Stock Against Markets
Xtant Medical Corporate Management
| Scott Neils | Chief Officer | Profile | |
| Kevin ODare | VP US | Profile | |
| Catherine Lundy | Vice Resources | Profile | |
| Mark Schallenberger | Chief Officer | Profile |
Already Invested in Xtant Medical Holdings?
The danger of trading Xtant Medical Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xtant Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xtant Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xtant Medical Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.